July 26, 2014 3:44 AM ET

Biotechnology

Company Overview of CoDa Therapeutics, Inc.

Company Overview

CoDa Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutics for wound care, inflammation, and tissue repair based on a gap junction modulation in the United States and Europe. The company offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was incorporated in 2005 and is based in San Diego, California.

10505 Sorrento Valley Road

Suite 395

San Diego, CA 92121

United States

Founded in 2005

Phone:

858-677-0474

Fax:

858-677-0475

Key Executives for CoDa Therapeutics, Inc.

Co-founder and Director
Co-Founder
Chief Financial Officer
Chief Operating Officer
Compensation as of Fiscal Year 2014.

CoDa Therapeutics, Inc. Key Developments

CoDa Therapeutics, Inc. Announces Positive Results from Phase 2b Study of NEXAGON(R) in Chronic Venous Leg Ulcers

CoDa Therapeutics, Inc. announced positive results from a Phase 2b clinical trial of NEXAGON(R) in patients with chronic venous leg ulcers. NEXAGON(R) is an easy to administer, once-a-week, topical, drug candidate being developed for the treatment of chronic wounds. It is designed to increase the incidence of wound healing compared to existing therapeutic techniques, and to heal them much faster. The company believes these results support advancing NEXAGON into Phase 3 registration trials. Venous leg ulcers are increasingly common and costly, and can be a cause of prolonged suffering for patients. NEXAGON(R) was safe, and showed an increase in complete healing in the randomized, vehicle-controlled, double-blind, Phase 2b study. CoDa is preparing a paper describing the results of this trial that will be submitted to a peer-reviewed medical journal.

Similar Private Companies By Industry

Company Name Region
SABiosciences Corporation United States
Pono Corp. United States
Accelerated Genetics, Inc. United States
Symbollon Pharmaceuticals Inc. United States
The GID Group, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
May 20, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CoDa Therapeutics, Inc., please visit www.codatherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.